BIOTECH

TRASE srl

TRASE's mission is to validate a marker of cerebral oxidative stress (European patent EP 2961848) that reflects neurodegenerative conditions, and Alzheimer's disease in particular, including in the early, pre-clinical stages. The marker is also a therapeutic target. TRASE addresses the pharmaceutical industry and the clinical diagnostics market.

BioTechDiagnostics

CROWDFUNDING SOON

Sector

BioTech

Focus

BioTech

Status

BiX Portfolio

MORE STARTUPS IN BIOTECH

Pharma Bullet

UPCOMING LAUNCH

FUNDRAISING COMING SOON

We are preparing the launch of a crowdfunding campaign to support the growth of TRASE srl. Sign up to receive all the details in preview.

KEEP ME POSTED